ClinicalTrials.Veeva

Menu

Efficacy of Polyethylene Glycol vs Lactulose With Isabgol in Acute Fissure-in-Ano: PEGASIS Trial

A

All India Institute of Medical Sciences, Bhubaneswar

Status and phase

Completed
Phase 3
Phase 2

Conditions

Anal Fissure
Constipation

Treatments

Drug: Isabgol + Lactulose
Drug: Polyethylene Glycol

Study type

Interventional

Funder types

Other

Identifiers

NCT05341180
IEC/AIIMS BBSR/PG Thesis/

Details and patient eligibility

About

The existing literature stresses the better efficacy of polyethylene glycol (PEG) over other stool softeners like lactulose or isabgol to improve functional constipation.

But there is no consensus regarding the efficacy of PEG alone vs lactulose combined with isabgol used as stool softeners, frequently used for relieving acute constipation in an acute fissure in ano. Hence a good quality randomised study to compare both efficacies is the need of the hour.

Full description

Acute fissure in ano is a very common, painful and distressing benign anorectal disorder. It is a linear tear in the anoderm of the distal anal canal most commonly on the posterior midline. They usually result from trauma caused by the passage of hard stool and less commonly from diarrhoea also. The most common presenting symptom is anal pain, bleeding and secondary constipation. Most of the cases are managed conservatively by increasing oral fluid intake, high fibre diet, sitz bath, stool softeners and topical application of sphincter muscle relaxants.

Constipation is one of the most common causes of anal fissure. Patients present to the outpatient department due to acute anal pain resulting from increased internal anal sphincter tone with spasms and hard stool rubbing over the crack. Constipation and pain due to anal fissure are initially managed with lifestyle and dietary modifications like consuming adequate fluids, increased fibre diet and sitz bath.

One of the fibre supplements is isabgol husk, a soluble fibre with enormous water-absorbing properties. Its added benefits include properties like non-irritant to the large bowel, non-fermenting, and dichotomous stool normalising agents, making it one of the most preferred bulk-forming agents. Low cost and over the counter availability are other benefits. Lactulose is also the most commonly prescribed laxative used in acute anal fissures to relieve constipation. Polyethylene glycol is a common osmotic laxative used for the relief of constipation in the treatment of anal fissures.

There are multiple studies that say polyethylene glycol has better efficacy in terms of frequency of stools, and form of stools compared to lactulose or isabgol husk alone. However, there are no studies conducted to compare the efficacy of polyethylene glycol vs combined use of isabgol husk and lactulose in relief of constipation in an acute fissure in ano. However, studies prove that laxatives may reduce/delay the absorption of certain medications, hence medications are advised to be taken 1 hour before or 2-3 hours after taking laxatives.

Patients in both arms will be advised to use local lidocaine with nifedipine cream (Anobliss cream from Samarth Life Sciences Pvt. Ltd., India). One arm will be given polyethylene glycol syrup for 2 weeks maximum and in the other arm, isabgol husk plus lactulose will be given for 2 weeks. Patients will be assessed at the end of a week, and 1 month and evaluated for primary and secondary outcomes.

Enrollment

144 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All patients presenting with acute fissure in ano between the age group of 18 to 75 years.

Exclusion criteria

  • Pregnancy / lactation

    • Patients not giving consent
    • Patients not able to understand the nature of the study
    • Diabetes mellitus and chronic kidney disease
    • Known intolerance to PEG/Lactulose or Isabgol
    • Prior enrolment in other study.
    • Patient undergoing surgery for Fissure in Ano

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

144 participants in 2 patient groups

Study group 1(Polyethylene Glycol)
Active Comparator group
Description:
Polyethylene glycol syrup will be used at a dose of 15-30 ml per day for 2 weeks maximum.
Treatment:
Drug: Polyethylene Glycol
Study group 2 (Isabgol and Lactulose)
Active Comparator group
Description:
Isabgol 2 teaspoons in 200ml of warm water to consume immediately after soaking before bedtime and syrup Lactulose 30 ml at bedtime for 2 weeks.
Treatment:
Drug: Isabgol + Lactulose

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Sai Krishna Aitha, MBBS,MS; Prakash Kumar Sasmal, MBBS,MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems